Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on September 28, 2006

Arteriosclerosis, Thrombosis, and Vascular Biology. 2006
Published online before print September 28, 2006, doi: 10.1161/01.ATV.0000247260.42560.e1
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
26/12/2724    most recent
01.ATV.0000247260.42560.e1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Post, S. M.
Right arrow Articles by Rensen, P. C.N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Post, S. M.
Right arrow Articles by Rensen, P. C.N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene

Submitted on March 29, 2006
Accepted on August 29, 2006

Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Increases Hepatic ABCA1 mRNA Expression and HDL-Cholesterol

Sabine M. Post ; Martine Groenendijk ; Caroline C. van der Hoogt ; Catherine Fievet ; Gérald Luc ; Menno Hoekstra ; Hans M.G. Princen ; Bart Staels ; and Patrick C.N. Rensen *

From TNO-Quality of Life, Department of Biomedical Research, (S.M.P., M.G., C.C.H., H.M.G.P., P.C.N.R.) Gaubius Laboratory, Leiden, The Netherlands; Département d’Athérosclérose and INSERM U545 (C.F., G.L., B.S.), Institut Pasteur de Lille and Faculté de Pharmacie, Université de Lille II, Lille, France; Leiden University Medical Center (C.C.H., P.C.N.R.), Department of General Internal Medicine, Endocrinology, and Metabolic Diseases, Leiden, The Netherlands; and Leiden/Amsterdam Center for Drug Research (M.H.), Division of Biopharmaceutics, Leiden, The Netherlands.

* To whom correspondence should be addressed. E-mail: P.C.N.Rensen{at}lumc.nl.

Objective--High-density lipoprotein (HDL) plays a key role in protection against development of atherosclerosis by reducing inflammation, protecting against LDL oxidation, and promoting reverse cholesterol transport from peripheral tissues to the liver for secretion into bile. Cholesterol 7{alpha}-hydroxylase (Cyp7a1) catalyzes the rate-limiting step in the intrahepatic conversion of cholesterol to bile acids that may have a role in HDL metabolism. We investigated the effect of Cyp7a1 deficiency on HDL metabolism in APOE*3-Leiden transgenic mice.

Methods and Results--Reduced bile acid biosynthesis in Cyp7a1-/-.APOE*3-Leiden mice versus APOE*3-Leiden mice did not affect total plasma cholesterol levels, but the distribution of cholesterol over various lipoproteins was different. Cholesterol was decreased in apoB-containing lipoproteins (ie, VLDL and IDL/LDL), whereas cholesterol was increased in HDL. The activity of PLTP and LCAT, which play a role in HDL catabolism, were not changed, and neither was HDL clearance. However, the hepatic cholesterol content was 2-fold increased, which was accompanied by a 2-fold elevated expression of hepatic ABCA1 and increased rate of cholesterol efflux from the liver to HDL.

Conclusions--Strongly reduced bile acid synthesis in Cyp7a1-/-.APOE*3-Leiden mice leads to increased plasma HDL-cholesterol levels, as related to an increased hepatic expression of ABCA1.


Key words: ATP binding cassette transporter A1 • bile acid synthesis • cholesterol 7{alpha}-hydroxylase • high-density lipoprotein • transgenic mice